NeuroSense Therapeutics Ltd. Conversion of Stock, Amount Issued
NeuroSense Therapeutics Ltd. (NRSN) reported Conversion of Stock, Amount Issued of $410.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2026-03-31
| Period end | Conversion of Stock, Amount Issued 12 month |
|---|---|
| 2025-12-31 | $410.00K 20-F · filed 2026-03-31 |